{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:15:03Z","timestamp":1768724103099,"version":"3.49.0"},"reference-count":167,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>A worldwide estimate of over one million STIs are acquired daily and there is a desperate need for effective preventive as well as therapeutic measures to curtail this global health burden. Vaccines have been the most effective means for the control and potential eradication of infectious diseases; however, the development of vaccines against STIs has been a daunting task requiring extensive research for the development of safe and efficacious formulations. Nanoparticle-based vaccines represent a promising platform as they offer benefits such as targeted antigen presentation and delivery, co-localized antigen-adjuvant combinations for enhanced immunogenicity, and can be designed to be biologically inert. Here we discuss promising types of nanoparticles along with outcomes from nanoparticle-based vaccine preclinical studies against non-viral STIs including chlamydia, syphilis, gonorrhea, and recommendations for future nanoparticle-based vaccines against STIs.<\/jats:p>","DOI":"10.3389\/fphar.2021.768461","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T08:44:11Z","timestamp":1638348251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections"],"prefix":"10.3389","volume":"12","author":[{"given":"Abisola","family":"Abisoye-Ogunniyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella M.","family":"Carrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina R.","family":"Weilhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean F.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas O.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"de la Maza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Rasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and Immunogenicity of the chlamydia Vaccine Candidate CTH522 Adjuvanted with CAF01 Liposomes or Aluminium Hydroxide: a First-In-Human, Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm-2016-0381","article-title":"Vaccine Nanoparticles for protection against HIV Infection","volume":"12","author":"Aikins","year":"2017","journal-title":"Nanomedicine (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jconrel.2005.08.003","article-title":"Preparation and Characterization of Biodegradable Nanoparticles Based on Poly(gamma-Glutamic Acid) with L-Phenylalanine as a Protein Carrier","volume":"108","author":"Akagi","year":"2005","journal-title":"J. Control. Release"},{"key":"B4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","article-title":"Nanoparticle-Based Vaccines against Respiratory Viruses","volume":"10","author":"Al-Halifa","year":"2019","journal-title":"Front. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/pharmaceutics13020206","article-title":"Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines","volume":"13","author":"Aldosari","year":"2021","journal-title":"Pharmaceutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00253-016-7315-0","article-title":"An Update on Polysaccharide-Based Nanomaterials for Antimicrobial Applications","volume":"100","author":"Arora","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1517\/17425241003777010","article-title":"Gold Nanoparticles: Opportunities and Challenges in Nanomedicine","volume":"7","author":"Arvizo","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1039\/c7cs00818j","article-title":"Protein Cage Assembly across Multiple Length Scales","volume":"47","author":"Aumiller","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.6091\/ibj.1242.2013","article-title":"Producing Gelatin Nanoparticles as Delivery System for Bovine Serum Albumin","volume":"18","author":"Azimi","year":"2014","journal-title":"Iran Biomed. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3389\/fimmu.2018.01981","article-title":"An Adaptive Chlamydia Trachomatis-specific IFN-\u03b3-Producing CD4+ T Cell Response Is Associated with Protection against Chlamydia Reinfection in Women","volume":"9","author":"Bakshi","year":"2018","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6805a1","article-title":"Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services","volume":"68","author":"Barrow","year":"2020","journal-title":"MMWR Recomm Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.molimm.2008.08.277","article-title":"Peptides Conjugated to Gold Nanoparticles Induce Macrophage Activation","volume":"46","author":"Bast\u00fas","year":"2009","journal-title":"Mol. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/molecules25010112","article-title":"The History of Nanoscience and Nanotechnology: From Chemical-Physical Applications to Nanomedicine","volume":"25","author":"Bayda","year":"2019","journal-title":"Molecules"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1038\/am.2016.128","article-title":"Engineering Protein Nanocages as Carriers for Biomedical Applications","volume":"9","author":"Bhaskar","year":"2017","journal-title":"NPG Asia Mater."},{"key":"B15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cbpa.2005.10.005","article-title":"Applications of Carbon Nanotubes in Drug Delivery","volume":"9","author":"Bianco","year":"2005","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jiec.2019.04.044","article-title":"Biodegradable Polymers for Modern Vaccine Development","volume":"77","author":"Bose","year":"2019","journal-title":"J. Ind. Eng. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as Nanomedical Devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia Infection: Implications for a Chlamydia trachomatis Vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2147\/IJN.S42723","article-title":"Formulation, Characterization, and Expression of a Recombinant MOMP Chlamydia trachomatis DNA Vaccine Encapsulated in Chitosan Nanoparticles","volume":"8","author":"Cambridge","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.vaccine.2013.09.053","article-title":"Current Status of Syphilis Vaccine Development: Need, Challenges, Prospects","volume":"32","author":"Cameron","year":"2014","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7150\/ntno.19796","article-title":"Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation","volume":"1","author":"Chattopadhyay","year":"2017","journal-title":"Nanotheranostics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-981-13-0445-3_2","article-title":"Protein Cage Nanoparticles as Delivery Nanoplatforms","volume":"1064","author":"Choi","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0232793","DOI":"10.1371\/journal.pone.0232793","article-title":"Factors Associated with Sexually Transmitted Infections Among Sexually Active Men in Ethiopia. Further Analysis of 2016 Ethiopian Demographic and Health Survey Data","volume":"15","author":"Dagnew","year":"2020","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00543","DOI":"10.1128\/CVI.00543-16","article-title":"Update on Chlamydia trachomatis Vaccinology","volume":"24","author":"de la Maza","year":"2017","journal-title":"Clin. Vaccin. Immunol"},{"key":"B25","first-page":"25","article-title":"Chlamydia trachomatis Today: Treatment, Detection, Immunogenetics and the Need for a Greater Global Understanding of Chlamydial Disease Pathogenesis","volume":"45","author":"Dean","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061717","article-title":"Protein Polymer-Based Nanoparticles: Fabrication and Medical Applications","volume":"19","author":"DeFrates","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/genes9070370","article-title":"Bioengineering Strategies for Protein-Based Nanoparticles","volume":"9","author":"Diaz","year":"2018","journal-title":"Genes (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biomaterials.2017.12.019","article-title":"Caveolin-mediated Endocytosis of the Chlamydia M278 Outer Membrane Peptide Encapsulated in Poly(lactic Acid)-Poly(ethylene Glycol) Nanoparticles by Mouse Primary Dendritic Cells Enhances Specific Immune Effectors Mediated by MHC Class II and CD4+ T Cells","volume":"159","author":"Dixit","year":"2018","journal-title":"Biomaterials"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.nano.2014.02.009","article-title":"Poly(lactic Acid)-Poly(ethylene Glycol) Nanoparticles Provide Sustained Delivery of a Chlamydia trachomatis Recombinant MOMP Peptide and Potentiate Systemic Adaptive Immune Responses in Mice","volume":"10","author":"Dixit","year":"2014","journal-title":"Nanomedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/kfj130","article-title":"Carbon Nanotubes: a Review of Their Properties in Relation to Pulmonary Toxicology and Workplace Safety","volume":"92","author":"Donaldson","year":"2006","journal-title":"Toxicol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1021\/cr300061w","article-title":"The Magic of Bicelles Lights up Membrane Protein Structure","volume":"112","author":"D\u00fcrr","year":"2012","journal-title":"Chem. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1039\/c1cs15166e","article-title":"Gold Nanoparticles in Biomedical Applications: Recent Advances and Perspectives","volume":"41","author":"Dykman","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/14760584.2020.1758070","article-title":"Gold Nanoparticles for Preparation of Antibodies and Vaccines against Infectious Diseases","volume":"19","author":"Dykman","year":"2020","journal-title":"Expert Rev. Vaccin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3109\/1040841X.2015.1105782","article-title":"Is Gonococcal Disease Preventable? the Importance of Understanding Immunity and Pathogenesis in Vaccine Development","volume":"42","author":"Edwards","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","article-title":"Chlamydia Cell Biology and Pathogenesis","volume":"14","author":"Elwell","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based Nanoparticles as Potential Controlled Release Drug Delivery Systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2147\/IJN.S44155","article-title":"Chlamydia trachomatis Recombinant MOMP Encapsulated in PLGA Nanoparticles Triggers Primarily T Helper 1 Cellular and Antibody Immune Responses in Mice: a Desirable Candidate Nanovaccine","volume":"8","author":"Fairley","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/82_2016_13","article-title":"Subversion of Cell-Autonomous Host Defense by Chlamydia Infection","volume":"412","author":"Fischer","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1021\/ja3063293","article-title":"Colocalized Delivery of Adjuvant and Antigen Using Nanolipoprotein Particles Enhances the Immune Response to Recombinant Antigens","volume":"135","author":"Fischer","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"B40","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1745-7580-6-S2-S1","article-title":"Computer Aided Selection of Candidate Vaccine Antigens","volume":"6","author":"Flower","year":"2010","journal-title":"Immunome Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2051013613480144","article-title":"Working Together: Interactions between Vaccine Antigens and Adjuvants","volume":"1","author":"Fox","year":"2013","journal-title":"Ther. Adv. Vaccin."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6030060","article-title":"Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization","volume":"6","author":"Gala","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fimmu.2018.00345","article-title":"Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1","volume":"9","author":"Gao","year":"2018","journal-title":"Front. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"498420","DOI":"10.1155\/2014\/498420","article-title":"Physicochemical Properties of Nanomaterials: Implication in Associated Toxic Manifestations","volume":"2014","author":"Gatoo","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"16244","DOI":"10.1021\/acs.langmuir.9b02077","article-title":"Aescin-Induced Conversion of Gel-phase Lipid Membranes into Bicelle-like Lipid Nanoparticles","volume":"35","author":"Geisler","year":"2019","journal-title":"Langmuir"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1900415","DOI":"10.1002\/mabi.201900415","article-title":"Nanoparticles Based on Hydrophobic Polysaccharide Derivatives-Formation Principles, Characterization Techniques, and Biomedical Applications","volume":"20","author":"Gericke","year":"2020","journal-title":"Macromol Biosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.4049\/jimmunol.1103032","article-title":"CD4+ T Cells Are Necessary and Sufficient to Confer protection against Chlamydia trachomatis Infection in the Murine Upper Genital Tract","volume":"189","author":"Gondek","year":"2012","journal-title":"J. Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/QCO.0000000000000343","article-title":"Future Prospects for New Vaccines against Sexually Transmitted Infections","volume":"30","author":"Gottlieb","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"589959","DOI":"10.3389\/fchem.2020.589959","article-title":"Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy","volume":"8","author":"Guevara","year":"2020","journal-title":"Front. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fimmu.2019.00321","article-title":"Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine","volume":"10","author":"Gulati","year":"2019","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid-polymer Hybrid Nanoparticles as a New Generation Therapeutic Delivery Platform: a Review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/polym10010031","article-title":"Polymer-Based Nanomaterials and Applications for Vaccines and Drugs","volume":"10","author":"Han","year":"2018","journal-title":"Polymers (Basel)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B54","doi-asserted-by":"publisher","first-page":"15121","DOI":"10.1074\/jbc.M117.784561","article-title":"Cell-free Production of a Functional Oligomeric Form of a Chlamydia Major Outer-Membrane Protein (MOMP) for Vaccine Development","volume":"292","author":"He","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.addr.2008.03.008","article-title":"Micelles and Nanoparticles for Ultrasonic Drug and Gene Delivery","volume":"60","author":"Husseini","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B56","first-page":"385","article-title":"Synthesis of Silver Nanoparticles: Chemical, Physical and Biological Methods","volume":"9","author":"Iravani","year":"2014","journal-title":"Res. Pharm. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","article-title":"Nanoemulsion: an Advanced Mode of Drug Delivery System","volume":"5","author":"Jaiswal","year":"2015","journal-title":"3 Biotech."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3762\/bjnano.9.98","article-title":"Review on Nanoparticles and Nanostructured Materials: History, Sources, Toxicity and Regulations","volume":"9","author":"Jeevanandam","year":"2018","journal-title":"Beilstein J. Nanotechnol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/vaccines5010003","article-title":"A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant","volume":"5","author":"Jiang","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking Vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1080\/17425247.2016.1193149","article-title":"Albumin Nanostructures as Advanced Drug Delivery Systems","volume":"13","author":"Karimi","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"B62","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1021\/acsbiomaterials.9b01427","article-title":"Synthesis and Characterization of Rapidly Degrading Polyanhydrides as Vaccine Adjuvants","volume":"6","author":"Kelly","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"B63","doi-asserted-by":"publisher","first-page":"8409","DOI":"10.2147\/IJN.S227514","article-title":"Poly(\u03b3-Glutamic Acid)\/Chitosan Hydrogel Nanoparticles for Effective Preservation and Delivery of Fermented Herbal Extract for Enlarging Hair Bulb and Enhancing Hair Growth","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 Major Capsid Protein Self-Assembles into Virus-like Particles that Are Highly Immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-virology-100114-055141","article-title":"Virus-Based Nanoparticles as Versatile Nanomachines","volume":"2","author":"Koudelka","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.imlet.2018.08.002","article-title":"Diversity in the T Cell Response to Chlamydia-Sum Are Better Than One","volume":"202","author":"Labuda","year":"2018","journal-title":"Immunol. Lett."},{"key":"B67","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1163\/092050610X492093","article-title":"Gelatin Nanoparticle Preparation by Nanoprecipitation","volume":"22","author":"Lee","year":"2011","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e2104511118","DOI":"10.1073\/pnas.2104511118","article-title":"DNA-inspired Nanomaterials for Enhanced Endosomal Escape","volume":"118","author":"Lee","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e64794","DOI":"10.1371\/journal.pone.0064794","article-title":"Non-cytotoxic Nanomaterials Enhance Antimicrobial Activities of Cefmetazole against Multidrug-Resistant Neisseria Gonorrhoeae","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1073\/pnas.1711356115","article-title":"Pathology after Chlamydia trachomatis Infection Is Driven by Nonprotective Immune Cells that Are Distinct from Protective Populations","volume":"115","author":"Lijek","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14760584.2016.1203262","article-title":"Vaccine Development for Syphilis","volume":"16","author":"Lithgow","year":"2017","journal-title":"Expert Rev. Vaccin."},{"key":"B72","doi-asserted-by":"publisher","first-page":"14273","DOI":"10.1038\/ncomms14273","article-title":"A Defined Syphilis Vaccine Candidate Inhibits Dissemination of Treponema pallidum Subspecies Pallidum","volume":"8","author":"Lithgow","year":"2017","journal-title":"Nat. Commun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41541-020-00238-8","article-title":"Technological Approaches to Streamline Vaccination Schedules, Progressing towards Single-Dose Vaccines","volume":"5","author":"Lofano","year":"2020","journal-title":"NPJ Vaccin."},{"key":"B74","doi-asserted-by":"publisher","first-page":"180549","DOI":"10.1155\/2014\/180549","article-title":"Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy","volume":"2014","author":"Lohcharoenkal","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling Protein Nanoparticles in the Design of Vaccines","volume":"14","author":"L\u00f3pez-Sagaseta","year":"2016","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"27994","DOI":"10.1021\/acsami.0c06163","article-title":"Bactericidal Effect of 5-Mercapto-2-Nitrobenzoic Acid-Coated Silver Nanoclusters against Multidrug-Resistant Neisseria Gonorrhoeae","volume":"12","author":"Luc\u00edo","year":"2020","journal-title":"ACS Appl. Mater. Inter."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.2147\/IJN.S203330","article-title":"Synthesis and Characterization of Nanometer-Sized Liposomes for Encapsulation and microRNA Transfer to Breast Cancer Cells","volume":"14","author":"Lujan","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-Co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/fsn3.827","article-title":"Development of Casein-Based Nanoencapsulation Systems for Delivery of Epigallocatechin Gallate and Folic Acid","volume":"7","author":"Malekhosseini","year":"2019","journal-title":"Food Sci. Nutr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2017.00239","article-title":"Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development","volume":"8","author":"Marques Neto","year":"2017","journal-title":"Front. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1021\/acs.biomac.7b00537","article-title":"Biodegradable \"Smart\" Polyphosphazenes with Intrinsic Multifunctionality as Intracellular Protein Delivery Vehicles","volume":"18","author":"Martinez","year":"2017","journal-title":"Biomacromolecules"},{"key":"B82","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/21691401.2017.1414825","article-title":"Pharmaceutical Aspects of Silver Nanoparticles","volume":"46","author":"Mathur","year":"2018","journal-title":"Artif. Cell Nanomed Biotechnol"},{"key":"B83","first-page":"779","article-title":"Novel Adjuvants & Delivery Vehicles for Vaccines Development: a Road Ahead","volume":"138","author":"Mohan","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/gt.2017.54","article-title":"Recombinant Elastin-Based Nanoparticles for Targeted Gene Therapy","volume":"24","author":"Monfort","year":"2017","journal-title":"Gene Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2017.12.005","article-title":"Supercharged green Fluorescent Protein Delivers HPV16E7 DNA and Protein into Mammalian Cells In Vitro and In Vivo","volume":"194","author":"Motevalli","year":"2018","journal-title":"Immunol. Lett."},{"key":"B86","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1039\/c8nr02278j","article-title":"Characterization Techniques for Nanoparticles: Comparison and Complementarity upon Studying Nanoparticle Properties","volume":"10","author":"Mourdikoudis","year":"2018","journal-title":"Nanoscale"},{"key":"B87","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/82_2016_18","article-title":"Immunopathogenesis of Chlamydial Infections","volume":"412","author":"Murthy","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1248\/cpb.c13-01004","article-title":"Fabrication of Solid Collagen Nanoparticles Using Electrospray Deposition","volume":"62","author":"Nagarajan","year":"2014","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0127669","DOI":"10.1371\/journal.pone.0127669","article-title":"Cry Protein Crystals: a Novel Platform for Protein Delivery","volume":"10","author":"Nair","year":"2015","journal-title":"PLoS One"},{"key":"B90","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.micinf.2015.08.004","article-title":"Host-pathogen Reorganisation during Host Cell Entry by Chlamydia trachomatis","volume":"17","author":"Nans","year":"2015","journal-title":"Microbes Infect."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/jid.2009.63","article-title":"Nanotechnology in Vaccine Development: a Step Forward","volume":"129","author":"Nasir","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.nano.2018.09.004","article-title":"Protein-based Nanoparticles in Cancer Vaccine Development","volume":"15","author":"Neek","year":"2019","journal-title":"Nanomedicine"},{"key":"B93","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41541-021-00330-7","article-title":"Protein-based Antigen Presentation Platforms for Nanoparticle Vaccines","volume":"6","author":"Nguyen","year":"2021","journal-title":"NPJ Vaccin."},{"key":"B94","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based Nanocarriers for Oral Peptide Delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e0008365","DOI":"10.1371\/journal.pntd.0008365","article-title":"Biodistribution of Degradable Polyanhydride Particles in Aedes aegypti Tissues","volume":"14","author":"Norris","year":"2020","journal-title":"Plos Negl. Trop. Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.virol.2004.06.047","article-title":"Enhanced Mucosal and Systemic Immunogenicity of Human Papillomavirus-like Particles Encapsidating Interleukin-2 Gene Adjuvant","volume":"328","author":"Oh","year":"2004","journal-title":"Virology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/humupd\/5.5.433","article-title":"Chlamydia trachomatis: Impact on Human Reproduction","volume":"5","author":"Paavonen","year":"1999","journal-title":"Hum. Reprod. Update"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1016\/j.vaccine.2017.03.070","article-title":"Comparison of the Nine Polymorphic Membrane Proteins of Chlamydia trachomatis for Their Ability to Induce Protective Immune Responses in Mice against a C. Muridarum challenge","volume":"35","author":"Pal","year":"2017","journal-title":"Vaccine"},{"key":"B99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41541-020-00235-x","article-title":"Induction of protection in Mice against a Respiratory challenge by a Vaccine Formulated with Exosomes Isolated from Chlamydia Muridarum Infected Cells","volume":"5","author":"Pal","year":"2020","journal-title":"NPJ Vaccin."},{"key":"B100","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as that Resulting from Inoculation with Live Bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect. Immun."},{"key":"B101","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jconrel.2020.12.031","article-title":"Lipid-based Vaccine Nanoparticles for Induction of Humoral Immune Responses against HIV-1 and SARS-CoV-2","volume":"330","author":"Park","year":"2021","journal-title":"J. Control. Release"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle Vaccines against Infectious Diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1743-422X-6-2","article-title":"An HPV 16 L1-Based Chimeric Human Papilloma Virus-like Particles Containing a String of Epitopes Produced in Plants Is Able to Elicit Humoral and Cytotoxic T-Cell Activity in Mice","volume":"6","author":"Paz De la Rosa","year":"2009","journal-title":"Virol. J."},{"key":"B104","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","article-title":"Nanotechnology in Vaccine Delivery","volume":"60","author":"Peek","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B105","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fmicb.2019.00070","article-title":"Seventy Years of Chlamydia Vaccine Research - Limitations of the Past and Directions for the Future","volume":"10","author":"Phillips","year":"2019","journal-title":"Front. Microbiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s11095-014-1528-7","article-title":"Drug-free Chitosan Coated Poly(isobutylcyanoacrylate) Nanoparticles Are Active against Trichomonas Vaginalis and Non-toxic towards Pig Vaginal Mucosa","volume":"32","author":"Pradines","year":"2015","journal-title":"Pharm. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.vaccine.2010.01.011","article-title":"Chitosan-based Nanoparticles for Improving Immunization against Hepatitis B Infection","volume":"28","author":"Prego","year":"2010","journal-title":"Vaccine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e1902791","DOI":"10.1002\/adma.201902791","article-title":"Rational Design of Nanocarriers for Intracellular Protein Delivery","volume":"31","author":"Qin","year":"2019","journal-title":"Adv. Mater."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1080\/21691401.2016.1241792","article-title":"A Review on green Synthesis of Silver Nanoparticles and Their Applications","volume":"45","author":"Rafique","year":"2017","journal-title":"Artif. Cell Nanomed Biotechnol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3389\/fimmu.2019.02615","article-title":"Editorial: Nanoparticle Vaccines against Infectious Diseases","volume":"10","author":"Reljic","year":"2019","journal-title":"Front. Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria Gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2018.06.028","article-title":"Immune Responses Induced by Nano-Self-Assembled Lipid Adjuvants Based on a Monomycoloyl Glycerol Analogue after Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein","volume":"285","author":"Rodrigues","year":"2018","journal-title":"J. Control. Release"},{"key":"B113","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.biomaterials.2014.10.053","article-title":"CD40-targeted Dendritic Cell Delivery of PLGA-Nanoparticle Vaccines Induce Potent Anti-tumor Responses","volume":"40","author":"Rosalia","year":"2015","journal-title":"Biomaterials"},{"key":"B114","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jconrel.2017.12.003","article-title":"A strong Adjuvant Based on Glycol-Chitosan-Coated Lipid-Polymer Hybrid Nanoparticles Potentiates Mucosal Immune Responses against the Recombinant Chlamydia trachomatis Fusion Antigen CTH522","volume":"271","author":"Rose","year":"2018","journal-title":"J. Control. Release"},{"key":"B115","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jconrel.2015.05.004","article-title":"Engineering of a Novel Adjuvant Based on Lipid-Polymer Hybrid Nanoparticles: A Quality-By-Design Approach","volume":"210","author":"Rose","year":"2015","journal-title":"J. Control. Release"},{"key":"B116","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-genet-120213-092007","article-title":"The Genetics of Neisseria Species","volume":"48","author":"Rotman","year":"2014","journal-title":"Annu. Rev. Genet."},{"key":"B117","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis: Global Prevalence and Incidence Estimates","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3389\/fimmu.2019.02417","article-title":"Progress toward a Gonococcal Vaccine: The Way Forward","volume":"10","author":"Russell","year":"2019","journal-title":"Front. Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"102257","DOI":"10.1016\/j.nano.2020.102257","article-title":"A Nanovaccine Formulation of Chlamydia Recombinant MOMP Encapsulated in PLGA 85:15 Nanoparticles Augments CD4+ Effector (CD44high CD62Llow) and Memory (CD44high CD62Lhigh) T-Cells in Immunized Mice","volume":"29","author":"Sahu","year":"2020","journal-title":"Nanomedicine"},{"key":"B120","doi-asserted-by":"publisher","first-page":"660932","DOI":"10.3389\/fimmu.2021.660932","article-title":"Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity against a Chlamydia Muridarum Genital Challenge and Re-Challenge","volume":"12","author":"Sahu","year":"2021","journal-title":"Front. Immunol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/14760584.2018.1435279","article-title":"Future of Human Chlamydia Vaccine: Potential of Self-Adjuvanting Biodegradable Nanoparticles as Safe Vaccine Delivery Vehicles","volume":"17","author":"Sahu","year":"2018","journal-title":"Expert Rev. Vaccin."},{"key":"B122","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/01.olq.0000154504.54686.d1","article-title":"Metaanalysis and Metaregression in Interpreting Study Variability in the Impact of Sexually Transmitted Diseases on Susceptibility to HIV Infection","volume":"32","author":"Sexton","year":"2005","journal-title":"Sex. Transm. Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"15971","DOI":"10.1039\/c9nr02408e","article-title":"Interplay between Ligand Mobility and Nanoparticle Geometry during Cellular Uptake of PEGylated Liposomes and Bicelles","volume":"11","author":"Shen","year":"2019","journal-title":"Nanoscale"},{"key":"B124","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 Vaccine Development and a Potential Nanomaterial Path Forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat. Nanotechnol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41565-020-00790-3","article-title":"Eliciting B Cell Immunity against Infectious Diseases Using Nanovaccines","volume":"16","author":"Singh","year":"2021","journal-title":"Nat. Nanotechnol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","article-title":"Presenting Native-like HIV-1 Envelope Trimers on Ferritin Nanoparticles Improves Their Immunogenicity","volume":"12","author":"Sliepen","year":"2015","journal-title":"Retrovirology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.vaccine.2006.11.049","article-title":"A Papillomavirus-like Particle (VLP) Vaccine Displaying HPV16 L2 Epitopes Induces Cross-Neutralizing Antibodies to HPV11","volume":"25","author":"Slupetzky","year":"2007","journal-title":"Vaccine"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1021\/mp200198c","article-title":"Intracellular Targeting of PLGA Nanoparticles Encapsulating Antigenic Peptide to the Endoplasmic Reticulum of Dendritic Cells and its Effect on Antigen Cross-Presentation In Vitro","volume":"8","author":"Sneh-Edri","year":"2011","journal-title":"Mol. Pharm."},{"key":"B129","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s41061-019-0277-9","article-title":"DNA-iron Oxide Nanoparticles Conjugates: Functional Magnetic Nanoplatforms in Biomedical Applications","volume":"378","author":"Sosa-Acosta","year":"2020","journal-title":"Top. Curr. Chem. (Cham)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"S380","DOI":"10.1086\/513844","article-title":"Chlamydia trachomatis Infections: Progress and Problems","volume":"179","author":"Stamm","year":"1999","journal-title":"J. Infect. Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2217\/fvl-2020-0174","article-title":"Nanoparticle Vaccines against Respiratory Syncytial Virus","volume":"15","author":"Stephens","year":"2020","journal-title":"Future Virol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1128\/iai.63.9.3302-3308.1995","article-title":"CD4+ T Cells Play a Significant Role in Adoptive Immunity to Chlamydia trachomatis Infection of the Mouse Genital Tract","volume":"63","author":"Su","year":"1995","journal-title":"Infect. Immun."},{"key":"B133","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In Vitro and In Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles","volume":"8","author":"Su","year":"2011","journal-title":"Mol. Pharm."},{"key":"B134","doi-asserted-by":"publisher","first-page":"325101","DOI":"10.1088\/0957-4484\/23\/32\/325101","article-title":"Biodegradable PLGA85\/15 Nanoparticles as a Delivery Vehicle for Chlamydia trachomatis Recombinant MOMP-187 Peptide","volume":"23","author":"Taha","year":"2012","journal-title":"Nanotechnology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/microorganisms7110557","article-title":"Sexually Transmitted Infections and Behavioral Determinants of Sexual and Reproductive Health in the Allahabad District (India) Based on Data from the ChlamIndia Study","volume":"7","author":"Thomas","year":"2019","journal-title":"Microorganisms"},{"key":"B136","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3389\/fimmu.2020.00945","article-title":"Nanoparticle Platforms for Antigen-specific Immune Tolerance","volume":"11","author":"Thorp","year":"2020","journal-title":"Front. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41541-020-0164-y","article-title":"A Single Dose Polyanhydride-Based Nanovaccine against Paratuberculosis Infection","volume":"5","author":"Thukral","year":"2020","journal-title":"NPJ Vaccin."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070755","article-title":"Induction of Protection in Mice against a Chlamydia Muridarum Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles","volume":"9","author":"Tifrea","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate Immune Recognition of Glycans Targets HIV Nanoparticle Immunogens to Germinal Centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"B140","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/bit.25311","article-title":"The Use of Hybrid Virus-like Particles to Enhance the Immunogenicity of a Broadly Protective HPV Vaccine","volume":"111","author":"Tyler","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.progpolymsci.2010.06.003","article-title":"Fabrication of Micellar Nanoparticles for Drug Delivery through the Self-Assembly of Block Copolymers","volume":"35","author":"Tyrrell","year":"2010","journal-title":"Prog. Polym. Sci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent Advances in Subunit Vaccine Carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines"},{"key":"B143","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/CMR.00105-13","article-title":"Genital Chlamydia trachomatis: Understanding the Roles of Innate and Adaptive Immunity in Vaccine Research","volume":"27","author":"Vasilevsky","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"B144","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/21505594.2015.1111509","article-title":"Chlamydial Polymorphic Membrane Proteins: Regulation, Function and Potential Vaccine Candidates","volume":"7","author":"Vasilevsky","year":"2016","journal-title":"Virulence"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3389\/fimmu.2018.02369","article-title":"The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic Acid)-Poly(ethylene Glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice against a Chlamydia Muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses","volume":"9","author":"Verma","year":"2018","journal-title":"Front. Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3238\/arztebl.2016.0011","article-title":"The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections","volume":"113","author":"Wagenlehner","year":"2016","journal-title":"Dtsch Arztebl Int."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.2147\/IJN.S30320","article-title":"Superparamagnetic Iron Oxide Nanoparticles: Magnetic Nanoplatforms as Drug Carriers","volume":"7","author":"Wahajuddin","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"B148","doi-asserted-by":"publisher","first-page":"CD012071","DOI":"10.1002\/14651858.CD012071.pub2","article-title":"Antibiotic Treatment for Newborns with Congenital Syphilis","volume":"2","author":"Walker","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.nano.2018.03.007","article-title":"Gold Nanoparticles Conjugating Recombinant Influenza Hemagglutinin Trimers and Flagellin Enhanced Mucosal Cellular Immunity","volume":"14","author":"Wang","year":"2018","journal-title":"Nanomedicine"},{"key":"B151","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcis.2013.11.019","article-title":"Effects of Nanoparticle Size and Charge on Interactions with Self-Assembled Collagen","volume":"417","author":"Wang","year":"2014","journal-title":"J. Colloid Interf. Sci"},{"key":"B152","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1039\/c3ib40165k","article-title":"Nanoparticles and Their Applications in Cell and Molecular Biology","volume":"6","author":"Wang","year":"2014","journal-title":"Integr. Biol. (Camb)"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/2211-5463.12267","article-title":"Structure-based Design of Ferritin Nanoparticle Immunogens Displaying Antigenic Loops of Neisseria Gonorrhoeae","volume":"7","author":"Wang","year":"2017","journal-title":"FEBS Open Bio"},{"key":"B154","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting Nanoparticle Vaccine Elicits a Therapeutic Antibody Response against Chronic Hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat. Nanotechnol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.vaccine.2017.02.004","article-title":"Enhancement of Antigen-specific CD4+ and CD8+ T Cell Responses Using a Self-Assembled Biologic Nanolipoprotein Particle Vaccine","volume":"35","author":"Weilhammer","year":"2017","journal-title":"Vaccine"},{"key":"B156","doi-asserted-by":"publisher","first-page":"10305","DOI":"10.1016\/j.biomaterials.2013.09.038","article-title":"The Use of Nanolipoprotein Particles to Enhance the Immunostimulatory Properties of Innate Immune Agonists against Lethal Influenza challenge","volume":"34","author":"Weilhammer","year":"2013","journal-title":"Biomaterials"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3389\/fimmu.2020.01264","article-title":"Characterization of Bacillus Anthracis Spore Proteins Using a Nanoscaffold Vaccine Platform","volume":"11","author":"Weilhammer","year":"2020","journal-title":"Front. Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e25343","DOI":"10.1002\/jia2.25343","article-title":"Diagnosing Sexually Transmitted Infections in Resource-Constrained Settings: Challenges and Ways Forward","volume":"22","author":"Wi","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"B159","doi-asserted-by":"publisher","first-page":"606","DOI":"10.7326\/0003-4819-148-8-200804150-00005","article-title":"Emerging Antimicrobial Resistance in Neisseria Gonorrhoeae: Urgent Need to Strengthen Prevention Strategies","volume":"148","author":"Workowski","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"B160","volume-title":"Report on Global Sexually Transmitted Infection Surveillance","year":"2018"},{"key":"B161","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fbioe.2020.00321","article-title":"Characterization and Immunogenicity of HIV Envelope Gp140 Zera\u00ae Tagged Antigens","volume":"8","author":"Ximba","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"11719","DOI":"10.1038\/srep11719","article-title":"Discovery of a Non-cationic Cell Penetrating Peptide Derived from Membrane-Interacting Human Proteins and its Potential as a Protein Delivery Carrier","volume":"5","author":"Young Kim","year":"2015","journal-title":"Sci. Rep."},{"key":"B163","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and Characterization of Virus-like Particles: a Review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.4161\/hv.7.10.16541","article-title":"Enhanced Immune Response and Protective Efficacy of a Treponema pallidum Tp92 DNA Vaccine Vectored by Chitosan Nanoparticles and Adjuvanted with IL-2","volume":"7","author":"Zhao","year":"2011","journal-title":"Hum. Vaccin."},{"key":"B165","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11427-012-4434-4","article-title":"Assessment of the Immune Responses to Treponema pallidum Gpd DNA Vaccine Adjuvanted with IL-2 and Chitosan Nanoparticles before and after Treponema pallidum challenge in Rabbits","volume":"56","author":"Zhao","year":"2013","journal-title":"Sci. China Life Sci."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.4161\/hv.29589","article-title":"Applications of Nanomaterials as Vaccine Adjuvants","volume":"10","author":"Zhu","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"B167","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00007435-200001000-00010","article-title":"Vaccines against Sexually Transmitted Infections: Promise and Problems of the Magic Bullets for Prevention and Control","volume":"27","author":"Zimet","year":"2000","journal-title":"Sex. Transm. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.768461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T08:44:18Z","timestamp":1638348258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.768461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":167,"alternative-id":["10.3389\/fphar.2021.768461"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.768461","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]},"article-number":"768461"}}